Nicotine dependence and illness severity in schizophrenia

British Journal of Psychiatry

Volumn 201, Issue 4, 2012, Pages 306-312

  Krishnadas, Rajeev ^a   Jauhar, Sameer ^b   Telfer, Susan ^c   Shivashankar, Somashekara ^d   McCreadie, Robin G ^e  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NHS LANARKSHIRE   (United Kingdom)

^d CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

^e Crichton Royal Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; SCHIZOPHRENIA; SCORING SYSTEM; SMOKING CESSATION; SOCIAL ADAPTATION; TOBACCO DEPENDENCE; UNEMPLOYMENT; UNITED KINGDOM;

CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCOTLAND; SEVERITY OF ILLNESS INDEX; SOCIAL ADJUSTMENT; TOBACCO USE DISORDER;

EID: 84866975460     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.111.107953     Document Type: Article

References (45)

1. deLeon J, Diaz F. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 2005; 76: 135-57. (Pubitemid 40812332)
2. Kelly DL, McMahon RP, Wehring HJ, Liu F, Mackowick KM, Boggs DL, et al. Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull 2011; 37: 832-8.
3. Kao Y-C, Liu Y-P, Cheng T-H, Chou M-K. Cigarette smoking in outpatients with chronic schizophrenia in Taiwan: relationships to socio-demographic and clinical characteristics. Psychiatr Res 2011; 190: 193-9.
4. Kotov R, Guey LT, Bromet EJ, Schwartz JE. Smoking in schizophrenia: diagnostic specificity, symptom correlates, and illness severity. Schizophr Bull 2008; 36: 173-81.
5. Barnes M, Lawford B, Burton S, Heslop K, Noble E, Hausdorf K, et al. Smoking and schizophrenia: is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use? Aust N Z J Psychiatry 2006; 6-7: 575-80. (Pubitemid 43805628)
6. Aguilar MC, Gurpegui M, Diaz FJ, De Leon J. Nicotine dependence and symptoms in schizophrenia: Naturalistic study of complex interactions. Br J Psychiatry 2005; 186: 215-21. (Pubitemid 40343815)
7. Patkar A, Gopalakrishnan R, Lundy A, Leone F, Certa K, Weinstein S. Relationship between tobacco smoking and positive and negative symptoms in schizophrenia. J Nerv Ment Dis 2005; 190: 604-10.
8. Herran A, deSantiago A, Sandoya M, Fernandez M, Dez-Manrique J, Vazquez-Barquero J. Determinants of smoking behaviour in outpatients with schizophrenia. Schizophr Res 2000; 41: 373-81. (Pubitemid 30077480)
9. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. WHO, 1992.
10. Telfer S, Shivashankar S, Krishnadas R, McCreadie RG, Kirkpatrick B. Tardive dyskinesia and deficit schizophrenia. Acta Psychiatr Scand 2011; 124: 357-62.
11. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-76. (Pubitemid 18039085)
12. de Leon J, Diaz FJ, Becona E, Gurpegui M, Jurado D, Gonzalez-Pinto A. Exploring brief measures of nicotine dependence for epidemiological surveys. Addict Behav 2003; 28: 1481-6. (Pubitemid 37152479)
13. Fagerstrom KO, Kunze M, Schoberberger R, Breslau N, Hughes JR, Hurt RD, et al. Nicotine dependence versus smoking prevalence: comparisons among countries and categories of smokers. Tob Control 1996; 5: 52-6. (Pubitemid 126670503)
14. Lane RD, Glazer WM, Hansen TE, Berman WH, Kramer SI. Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale. J Nerv Ment Dis 1985; 173: 353-7. (Pubitemid 15079180)
15. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry 1989; 154: 672-6. (Pubitemid 19154942)
16. Simpson G, Angus J. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970; 212: 11-19.
17. Kirkpatrick B, Buchanan RW, Breier A, Carpenter Jr WT. Case identification and stability of the deficit syndrome of schizophrenia. Psychiatry Res 1993; 47: 47-56. (Pubitemid 23149395)
18. Weissman MM, Bothwell S. Assessment of social adjustment by patient self-report. Arch Gen Psychiatry 1976; 33: 1111-5.
19. World Health Organization. Guidelines for ATC Classification and DDD Assignment (13th edn). WHO Collaborating Centre for Drugs Statistics Methodology, 2009.
20. Palaniyappan L, Liddle PF. Differential effects of surface area, gyrification and cortical thickness on voxel based morphometric deficits in schizophrenia. Neuroimage 2012; 60: 693-9.
21. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008; 40: 879-91.
22. Whyte B, Gordon D, Haw S, Fischerbacher C, Scott N, Harrison R. An Atlas of Tobacco Smoking in Scotland: A Report Presenting Estimated Smoking Prevalence and Smoking Attributable Deaths within Scotland. NHS Health Scotland, 2007.
23. Kelly C, McCreadie R. Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am J Psychiatry 1999; 156: 1751-7. (Pubitemid 29517568)
24. Tandon R, Nasrallah HA, Keshavan MS. Schizophrenia, 'just the facts' 4. Clinical features and conceptualization. Schizophr Res 2009; 110: 1-23.
25. Myles N, Newall H, Compton MT, Curtis J, Nielssen O, Large M. The age at onset of psychosis and tobacco use: a systematic meta-analysis. Soc Psychiatry Psychiatr Epidemiol 2011; Sep 8. Epub ahead of print.
26. Pierce JP, Dwyer T, DiGiusto E, Carpenter T, Hannam C, Amin A, et al. Cotinine validation of self-reported smoking in commercially run community surveys. J Chronic Dis 1987; 40: 689-95. (Pubitemid 17113475)
27. Panday S, Reddy SP, Ruiter RA, Bergstrom E, de Vries H. Nicotine dependence and withdrawal symptoms among occasional smokers. J Adolesc Health 2007; 40: 144-50. (Pubitemid 46149364)
28. Levander S, Eberhard J, Lindstrom E. Nicotine use and its correlates in patients with psychosis. Acta Psychiatr Scand 2007; 116(S435): 27-32. (Pubitemid 47621732)
29. Weinberger AH, Reutenauer EL, Allen TM, Termine A, Vessicchio JC, Sacco KA, et al. Reliability of the Fagerstrom Test for Nicotine Dependence, Minnesota Nicotine Withdrawal Scale, and Tiffany Questionnaire for Smoking Urges in smokers with and without schizophrenia. Drug Alcohol Depend 2007; 86: 278-82. (Pubitemid 44821602)
30. Salokangas R, Saarijarvi S, Taiminen T, Lehto H, Niemi H, Ahola V, et al. Effect of smoking on neuroleptics in schizophrenia. Schizophr Res 1997; 23: 55-60. (Pubitemid 27095191)
31. Yang YK, Nelson L, Kamaraju L, Wilson W, McEvoy JP. Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia. Neuropsychopharmacology 2002; 27: 684-6.
32. Zhang XY, Yu YQ, Sun S, Zhang X, Li W, Xiu MH, et al. Smoking and tardive dyskinesia in male patients with chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 1765-9.
33. Winterer G. Why do patients with schizophrenia smoke? Curr Opin Psychiatry 2010; 23: 112-9.
34. Matthews A, Wilson V, Mitchell S. The role of antipsychotics in smoking and smoking cessation. CNS Drugs 2011; 25: 299-315.
35. Kumari V, Postma P. Nicotine use in schizophrenia: The self medication hypotheses. Neurosci Biobehav Rev 2005; 29: 1021-34. (Pubitemid 41097398)
36. George Y. Neurobiological links between nicotine addiction and schizophrenia. J Dual Diagn 2007; 3: 27-42.
37. Brody A, Olmstead R, London E, Farahi J, Meyer J, Grossman P, et al. Smoking induced ventral striatum dopamine release. Am J Psychiatry 2004; 161: 1211-8. (Pubitemid 38859170)
38. Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III - the final common pathway. Schizophr Bull 2009; 35: 549-62.
39. Jacobsen LK, D'Souza DC, Mencl WE, Pugh KR, Skudlarski P, Krystal JH. Nicotine effects on brain function and functional connectivity in schizophrenia. Biol Psychiatry 2004; 55: 850-8. (Pubitemid 38429877)
40. Zhang XY, Chen da C, Xiu MH, Haile CN, Sun H, Lu L, et al. Cigarette smoking and cognitive function in chinese male schizophrenia: a case-control study. PLoS ONE 2012; 7: e36563.
41. Strauss E, Sherman EMS, Spreen O. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary (3rd edn). Oxford University Press, 2006.
42. Esterberg ML, Jones EM, Compton MT, Walker EF. Nicotine consumption and schizotypy in first-degree relatives of individuals with schizophrenia and non-psychiatric controls. Schizophr Res 2007; 97: 6-13. (Pubitemid 350088403)
43. Yoshimasu K, Kiyohara C. Genetic influences on smoking behavior and nicotine dependence: a review. J Epidemiol 2003; 13: 183-92. (Pubitemid 44130741)
44. Wing VC, Wass CE, Soh DW, George TP. A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia. Ann N Y Acad Sci 2011; 1248: 89-106.
45. Brunzell DH, McIntosh JM. Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia. Neuropsychopharmacology 2011; 37: 1134-43.